SynopsisThe global Portable Medical Refrigerator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devic.....
Synopsis Tissue plasminogen activator (abbreviated tPA or PLAT) is a protein involved in the breakdown of blood clots. It is a serine protease found on endothelial cells, the cells that line the blood vessels. As an enzyme, it catalyzes the conversion .....
SynopsisTransosteal implants are another type of dental implant used when there is minimal bone height in the jaw. They are inserted through the bone and extend into the mouth, providing stability for dental prosthetics. The global Transosteal Implants market si.....
SynopsisThe global Hernia Surgical Mesh Implants market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hernia Surgical Mesh Implants in various end use industries......
SynopsisThe Partial Knee Replacement (PKR) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Partia.....
SynopsisWheeled Examination Lamp so constructed that an intense light is emitted through a slit; used for examination of the eye. The global Wheeled Examination Lamps market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witne.....
SynopsisPegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was first launched by Amgen Inc. as Neulasta in 2002. Later, several biosimilars of pegfilgrastim were launched in .....
SynopsisPeripheral drug-coated balloons (DCBs) are minimally invasive angioplasty balloons coated in paclitaxel, an anti-proferative drug that is released up dilatation of the balloon within a peripheral artery to treat peripheral artery disease (PAD). The globa.....
SynopsisCRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older. Market Analysis and Insights: Global Crysvita Market The global Crysvita market was valued at US$ XX in 202.....
SynopsisThe rising geriatric population, increasing adoption of safety syringes, technological advancements, and increasing demand for vaccines are supporting the growth of this market. The global Syringes (Disposable and Reusable) market was valued at US$ milli.....
